reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301–
1306.
Boado R. J., Li J. Y., Nagaya M., Zhang C. and Pardridge W. M. (1999)
Selective expression of the large neutral amino acid transporter at the
blood–brain barrier. Proc. Natl Acad. Sci. USA 96, 12079–12084.
Di Monte D. A. (2001) The role of environmental agents in Parkinson's
disease. Clin. Neurosci. Res. 1, 419–426.
Furuno T., Landi M. T., Ceroni M., Caporaso N., Bernucci I., Nappi G.,
Martignoni E., Schaeffeler E., Eichelbaum M., Schwab M. and
Zanger U. M. (2002) Expression polymorphism of the blood–brain
barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics 12, 529–534.
Kageyama T., Nakamura M., Matsuo A., Yamasaki Y., Takakura Y.,
Hashida M., Kanai Y., Naito M., Tsuruo T., Minato N. and Shimohama S. (2000) The 4F2hc/LAT1 complex transports L-DOPA
across the blood–brain barrier. Brain Res. 879, 115–121.
Koller W. C. (1986) Paraquat and Parkinson's disease. Neurology 36, 1147.
McCormack A. L., Thiruchelvam M., Manning-Bog A. B., Thiffault C.,
Langston J. W., Cory-Slechta D. A. and Di Monte D. A. (2002)
Environmental risk factors and Parkinson's disease: selective
degeneration of nigral dopaminergic neurons caused by the
herbicide paraquat. Neurobiol. Dis. 10, 119–127.
